These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33744086)

  • 1. Clinical outcomes and healthcare expenditures in the real world with left ventricular assist devices - The CLEAR-LVAD study.
    Pagani FD; Mehra MR; Cowger JA; Horstmanshof DA; Silvestry SC; Atluri P; Cleveland JC; Lindenfeld J; Roberts GJ; Bharmi R; Dalal N; Kormos RL; Rogers JG
    J Heart Lung Transplant; 2021 May; 40(5):323-333. PubMed ID: 33744086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure.
    Lala A; Rowland JC; Ferket BS; Gelijns AC; Bagiella E; Pinney SP; Moskowitz AJ; Miller MA; Pagani FD; Mancini DM
    JAMA Cardiol; 2020 Jun; 5(6):652-659. PubMed ID: 32293643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporary left ventricular assist devices as a bridge to heart transplantation.
    Seese L; Hickey G; Keebler ME; Mathier MA; Sultan I; Gleason TG; Wang Y; Kilic A
    J Card Surg; 2020 Apr; 35(4):810-817. PubMed ID: 32092194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Related Differences in Use and Outcomes of Left Ventricular Assist Devices as Bridge to Transplantation.
    DeFilippis EM; Truby LK; Garan AR; Givens RC; Takeda K; Takayama H; Naka Y; Haythe JH; Farr MA; Topkara VK
    JACC Heart Fail; 2019 Mar; 7(3):250-257. PubMed ID: 30819381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of heart transplant outcomes between recipients with pulsatile- vs continuous-flow LVAD.
    Yazdchi F; Rajab TK; Rinewalt D; Loberman D; Shekar P; Percy E; Hirji S; Urban R; Lehman RR; Mallidi HR; Singh SK
    J Card Surg; 2019 Oct; 34(10):1062-1068. PubMed ID: 31389644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after left ventricular assist device with and without temporary right ventricular support.
    Lazar JF; Swartz MF; Schiralli MP; Schneider M; Pisula B; Hallinan W; Hicks GL; Massey HT
    Ann Thorac Surg; 2013 Dec; 96(6):2155-9. PubMed ID: 24035303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Center Variation in Medicare Spending for Durable Left Ventricular Assist Device Implant Hospitalizations.
    Thompson MP; Pagani FD; Liang Q; Franko LR; Zhang M; McCullough JS; Strobel RJ; Aaronson KD; Kormos RL; Likosky DS;
    JAMA Cardiol; 2019 Feb; 4(2):153-160. PubMed ID: 30698605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support.
    Urban M; Pirk J; Szarszoi O; Besik J; Netuka I
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
    Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
    Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).
    Lanfear DE; Levy WC; Stehlik J; Estep JD; Rogers JG; Shah KB; Boyle AJ; Chuang J; Farrar DJ; Starling RC
    Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28465311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.
    Arnaoutakis GJ; George TJ; Kilic A; Weiss ES; Russell SD; Conte JV; Shah AS
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1236-45, 1245.e1. PubMed ID: 21839482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and Sex Inequities in the Use of and Outcomes After Left Ventricular Assist Device Implantation Among Medicare Beneficiaries.
    Cascino TM; Somanchi S; Colvin M; Chung GS; Brescia AA; Pienta M; Thompson MP; Stewart JW; Sukul D; Watkins DC; Pagani FD; Likosky DS; Aaronson KD; McCullough JS
    JAMA Netw Open; 2022 Jul; 5(7):e2223080. PubMed ID: 35895063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Wever-Pinzon O; Drakos SG; Kfoury AG; Nativi JN; Gilbert EM; Everitt M; Alharethi R; Brunisholz K; Bader FM; Li DY; Selzman CH; Stehlik J
    Circulation; 2013 Jan; 127(4):452-62. PubMed ID: 23271796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of cardiac transplantation in patients requiring prolonged continuous-flow left ventricular assist device support.
    Takeda K; Takayama H; Kalesan B; Uriel N; Colombo PC; Jorde UP; Yuzefpolskaya M; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 Jan; 34(1):89-99. PubMed ID: 25444372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal cannula positioning of HeartMate 3 left ventricular assist device.
    Imamura T; Narang N; Nitta D; Fujino T; Nguyen A; Kim G; Raikhelkar J; Rodgers D; Ota T; Jeevanandam V; Sayer G; Uriel N
    Artif Organs; 2020 Dec; 44(12):e509-e519. PubMed ID: 32557769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-institutional retrospective analysis on impact of RV acute mechanical support timing after LVAD implantation on 1-year mortality and predictors of RV acute mechanical support weaning.
    Kumar S; Derbala MH; Nguyen DT; Ferrall J; Cefalu M; Rivas-Lasarte M; Rashid SMI; Joseph DT; Graviss EA; Goldstein D; Jorde UP; Bhimaraj A; Suarez EE; Smith SA; Sims DB; Guha A
    J Heart Lung Transplant; 2022 Feb; 41(2):244-254. PubMed ID: 34802875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.